Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Accepted on 04 Sep 2025

Association of dexmedetomidine with short-term outcome in patients with cardiogenic shock: a retrospective propensity score-matched cohort study from MIMIC-IV

in Inflammation Pharmacology

Linfeng Xie
Jing Chen
Bryan Richard Sasmita
Yuanzhu Li
Suxin Luo
Bi Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1644635

301 views

Review

Accepted on 04 Sep 2025

Advances in Drug Delivery Systems for the Management of Gou t and Hyperuricemia

in Inflammation Pharmacology

Zining Peng
Fanyu Meng
Qian Deng
Yuanbo Huang
Danning Mao
Yuan Long
Yan Weitian
Jiangyun Peng
Xingqiang Wang
Nian Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1660890

295 views

Original Research

Published on 04 Sep 2025

Mitochondria-target ubiquinone attenuates bleomycin-induced pulmonary fibrosis

in Inflammation Pharmacology

Ying Jiang
Zhenghui Huang
Ting Zhou
Mi Wu
Juan Zhao
Zheyi Xiong
Rui Wang
Limin Chen
Xiufang Weng
Lan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1661644

589 views

Original Research

Published on 02 Sep 2025

In situ sustained release of icariin from injectable thermosensitive PLGA-PEG-PLGA hydrogels combined with core decompression for steroid-induced osteonecrosis of femoral head

in Inflammation Pharmacology

Yingxing Xu
Kaige Xu
Zehua Wang
Xinyu Tang
Yaping Jiang
Tao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1643316

568 views

Correction

Accepted on 01 Sep 2025

Correction: Research progress in treatment of rheumatoid arthritis with Sinomenine and related formulations based on different administration routes

in Inflammation Pharmacology

Wenya Wang
Zihui Wang
Aixia Ling
Chunyan Zhang
Mei Lv
Lufen Huang
Yanlian Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1685111

257 views

Review

Accepted on 01 Sep 2025

Role of N6-Methyladenosine (m6A) Epitranscriptomic Mark in Regulating Viral Infections and Target for Antiviral Development

in Inflammation Pharmacology

Mahmoud Bayoumi
Vidya Manju
Luis Martinez-Sobrido
Muhammad Munir

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1667283

222 views

Original Research

Published on 01 Sep 2025

Exploring the potential of a thermosensitive in situ gel with Periplaneta americana extracts for efficient wound healing

in Inflammation Pharmacology

Shuai Liu
Shuohan Xu
Hang Lu
Xueyu Gong
Huaipeng Li
Xinyu Fan
Hongwei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1672818

400 views

Original Research

Accepted on 31 Aug 2025

Prostaglandin E2 stimulates opposing effects on inner and outer blood-retina barrier function

in Inflammation Pharmacology

Amy Kathryn Stark
John Sidney Penn

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1608376

167 views

Mini Review

Accepted on 29 Aug 2025

Promising therapeutics of enterovirus 71 infection: sunshine behind cloud

in Inflammation Pharmacology

Sheng-Yu You
Shun-Hua Chen
Shih-Min Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1652159

241 views

Review

Accepted on 28 Aug 2025

GLP-1 receptor agonists: exploration of transformation from metabolic regulation to multi-organ therapy

in Inflammation Pharmacology

Bing Gong
Couwen Li
Zhuange Shi
FuPing Wang
Ruanxian Dai
Guobing Chen
Heng Su

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1675552

350 views

Original Research

Published on 28 Aug 2025

Opposing profiles of Netrin-1 and adiponectin in metabolic inflammation and insulin resistance

in Inflammation Pharmacology

María Guadalupe Ramos-Zavala
Jesús Jonathan García-Galindo
Alberto Beltrán-Ramírez
Luis Ricardo Balleza-Alejandri
Emiliano Peña-Durán
Alfredo Huerta-Huerta
Edy David Rubio-Arellano
Luis Daniel López-Murillo
Sara Pascoe-Gonzalez
Tannia Isabel Campos-Bayardo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1632956

1,123 views

Original Research

Accepted on 26 Aug 2025

Inhibition of soluble epoxide hydrolase in endotoxin induced pig lung injury

in Inflammation Pharmacology

Niklas Larsson
Cindy B Mcreynolds
Sung Hee Hwang
Debin Wan
Jun Yang
Richard Lindberg
Stefan Lehtipalo
Jonas Claesson
Amanda Irgum Liljeström
Alicia Lind

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1652349

346 views

Original Research

Accepted on 21 Aug 2025

Empagliflozin Targeting STAT3/Akt/Nrf2 Axis Promoting Diabetic Wound Healing in Rat Model

in Inflammation Pharmacology

Rania M Magadmi
Dalal Alfawaz
Ahmed Bakhshwin
Fatmah Binzomah Alghamdi
Sultan Alfawaz
Duaa Bakhshwin
Maha Jamal
Roba A Sofi
Ahmed Esmat

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1678552

330 views

Review

Published on 21 Aug 2025

Apremilast treatment of immune-mediated inflammatory skin diseases: a narrative review

in Inflammation Pharmacology

Xiaoqian Liang
Jiecheng Zheng
Xueyi Huang
Min Tan
Jia Liao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1633426

629 views

Systematic Review

Published on 21 Aug 2025

Efficacy and safety of topical vs. oral calcium channel blockers for chronic anal fissures: a systematic review and meta-analysis

in Inflammation Pharmacology

Tianshuo Li
Pengfei Ye
Xinli He
Chen Li
Lanlan Xi
Zuowu Xi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1642347

659 views

Correction

Published on 21 Aug 2025

Correction: α-Mangostin alleviated inflammation in rats with adjuvant-induced arthritis by disrupting adipocytes-mediated metabolism-immune feedback

in Inflammation Pharmacology

Ying-Hao Hu
Jun Han
Lin Wang
Chao Shi
Yan Li
Opeyemi Joshua Olatunji
Xiu Wang
Jian Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1671368

210 views